Mercaptopurine Tablet
Product Images NDC 51407-983

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mercaptopurine (NDC 51407-983). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-983-25ol (Mercaptopurine Tablets 50 mg)

51407-983-25ol (Mercaptopurine Tablets 50 mg)
Label for Mercaptopurine 50 mg oral tablets, USP, identified as a cytotoxic agent. The label includes the NDC 51407-983-25 and indicates a bottle size of 250 tablets. Marketed by GSMS, Incorporated, Camarillo, CA. The label provides storage instructions and warnings about medical supervision and child safety.*
FDA Label Image

Image-01.jpg (Image 01)

Image-01.jpg (Image 01)
Chemical structure of Mercaptopurine monohydrate showing the molecular arrangement including sulfur and nitrogen atoms within a purine ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.